| 1 |
-
Clinical characteristics and treatment patterns of older and younger patients with inflammatory bowel disease
-
7/14/2026 7:33:58 AM | Browse: 25 | Download: 65
|
| 2 |
-
Ethnic divergence in human leukocyte antigen-linked immunogenicity in inflammatory bowel disease
-
6/30/2026 1:35:11 PM | Browse: 38 | Download: 140
|
| 3 |
-
Letter to the Editor: Decoding pediatric-adult divergence in inflammatory bowel disease via multi-omics integration
-
6/12/2026 10:39:45 AM | Browse: 52 | Download: 197
|
| 4 |
-
Association between proton pump inhibitor use and the risk of inflammatory bowel disease: A systematic review and meta-analysis
-
5/29/2026 7:26:45 AM | Browse: 52 | Download: 225
|
| 5 |
-
Circadian clock at the interface of mucosal immunity, gut microbiota and epithelial barrier in inflammatory bowel disease
-
5/29/2026 7:26:45 AM | Browse: 45 | Download: 192
|
| 6 |
-
Surgical interventions in inflammatory bowel disease: Indications, techniques, outcomes, and future directions
-
5/27/2026 8:10:54 AM | Browse: 44 | Download: 205
|
| 7 |
-
Letter to the Editor: Missing mechanistic data and small inflammatory bowel disease cohorts: Key barriers in ustekinumab switching
-
5/18/2026 10:29:14 AM | Browse: 60 | Download: 145
|
| 8 |
-
Insights into the pathogenic roles and targeted therapy of neutrophil extracellular traps in inflammatory bowel disease
-
4/24/2026 5:43:48 AM | Browse: 84 | Download: 225
|
| 9 |
-
Risk factors associated with anxiety and depression in patients with inflammatory bowel disease identified using structural equation modeling
-
3/30/2026 8:58:27 AM | Browse: 98 | Download: 357
|
| 10 |
-
Efficacy and safety of dual-targeted therapy in children with inflammatory bowel disease: Retrospective cohort study
-
3/6/2026 8:56:29 AM | Browse: 111 | Download: 521
|
| 11 |
-
Comparable remission and health care use in real-world inflammatory bowel disease patients initiating originator biologics vs biosimilars
-
2/27/2026 8:35:13 AM | Browse: 108 | Download: 372
|
| 12 |
-
Artificial intelligence and digital transformation of gastroenterology and hepatology: A critical review of clinical applications and future challenges
-
2/12/2026 11:20:21 AM | Browse: 164 | Download: 494
|
| 13 |
-
Targeting Dialister-driven succinate accumulation: A novel strategy for Crohn’s disease activity control and recurrence prevention
-
2/11/2026 7:19:24 AM | Browse: 230 | Download: 335
|
| 14 |
-
Artificial intelligence in the management of inflammatory bowel disease: What’s next?
-
2/11/2026 3:41:42 AM | Browse: 103 | Download: 372
|
| 15 |
-
Harnessing artificial intelligence in gastrointestinal endoscopy for early detection of dysplastic lesions in inflammatory bowel disease
-
2/4/2026 7:43:03 AM | Browse: 143 | Download: 373
|
| 16 |
-
Altered endocannabinoid system gene expression in inflammatory bowel disease mucosa: New perspectives in inflammatory bowel disease management
-
2/4/2026 7:43:02 AM | Browse: 134 | Download: 435
|
| 17 |
-
Revisiting HLA-DQA1*05 in Asian inflammatory bowel disease cohorts: Ethnic variations in genetic susceptibility to immunogenicity
-
1/28/2026 9:23:39 AM | Browse: 111 | Download: 231
|
| 18 |
-
Psychological and hematological factors associated with fatigue in patients with Crohn’s disease receiving pharmacological treatment
-
1/28/2026 9:23:38 AM | Browse: 224 | Download: 349
|
| 19 |
-
Determination of correlation of clearance with clinical outcomes for inflammatory bowel disease
-
1/28/2026 9:23:38 AM | Browse: 148 | Download: 419
|
| 20 |
-
Growth differentiation factor 15 - a new molecular target in inflammatory bowel disease: Progress and challenges
-
1/28/2026 9:23:38 AM | Browse: 169 | Download: 258
|
| 21 |
-
Latent tuberculosis screening for inflammatory bowel disease in tuberculosis endemic region remains porous and suboptimal: A multicentre study
-
1/22/2026 8:14:10 AM | Browse: 204 | Download: 579
|
| 22 |
-
Antibiotic consumption of inpatients with inflammatory bowel disease during 2015-2024 and future prediction: Evidence from a general hospital
-
1/22/2026 8:14:09 AM | Browse: 211 | Download: 426
|
| 23 |
-
Role of leucine-rich α-2-glycoprotein in Taiwanese patients with inflammatory bowel disease as a predictive biomarker for endoscopic activity
-
1/16/2026 11:31:12 AM | Browse: 137 | Download: 579
|
| 24 |
-
Science of fecal microbiota transplant: From history to cutting-edge clinical practice
-
1/15/2026 3:35:07 AM | Browse: 127 | Download: 311
|
| 25 |
-
Discontinuation of advanced therapy in inflammatory bowel disease: Updated evidence, guidelines, and personalized decision-making one year later
-
1/5/2026 6:55:13 AM | Browse: 149 | Download: 416
|
| 26 |
-
Exploring exercise modalities and their impact on inflammatory bowel disease: A systematic review of rodent colitis models
-
12/27/2025 2:50:54 AM | Browse: 230 | Download: 552
|
| 27 |
-
Combined metabolomic and metagenomic analysis reveals inflammatory bowel disease diversity in pediatric and adult patients
-
12/27/2025 2:50:53 AM | Browse: 265 | Download: 651
|
| 28 |
-
Clinical outcomes and drug sustainability after non-medical switch from ustekinumab originator to biosimilars in inflammatory bowel disease
-
12/27/2025 2:50:53 AM | Browse: 247 | Download: 558
|
| 29 |
-
Relationship between Epstein-Barr virus and inflammatory bowel disease
-
12/27/2025 2:50:52 AM | Browse: 131 | Download: 350
|
| 30 |
-
Molecular links between inflammatory bowel disease and Alzheimer’s disease through immune signaling and inflammatory pathways
-
12/27/2025 2:50:51 AM | Browse: 133 | Download: 409
|
| 31 |
-
Dual biologic therapy in patient with refractory ulcerative colitis and comorbidities: A case report
-
12/19/2025 10:39:41 AM | Browse: 225 | Download: 404
|
| 32 |
-
Endometrial stromal sarcoma in a patient with ulcerative colitis receiving immunosuppressive therapy: A case report and review of literature
-
12/16/2025 6:42:01 AM | Browse: 165 | Download: 508
|
| 33 |
-
Emerging role of Janus kinase inhibitors in ulcerative colitis management
-
12/5/2025 11:28:04 AM | Browse: 186 | Download: 409
|
| 34 |
-
Neuroimmune interactions in inflammatory bowel disease: Role of intestinal macrophages and the cholinergic pathway
-
11/28/2025 3:10:36 AM | Browse: 142 | Download: 452
|
| 35 |
-
Prudence is never excessive: Caution warranted in 5-aminosalicylic acid derivatives withdrawal for ulcerative colitis
-
11/28/2025 3:10:35 AM | Browse: 239 | Download: 471
|
| 36 |
-
Targeting pyroptosis in inflammatory bowel disease: A potentially effective therapeutic approach
-
11/20/2025 7:56:50 AM | Browse: 166 | Download: 437
|
| 37 |
-
Management of peritoneal metastases from colorectal cancer and small bowel adenocarcinoma in patients with inflammatory bowel disease
-
11/14/2025 12:56:12 AM | Browse: 131 | Download: 406
|
| 38 |
-
Research progress concerning the involvement of the intestinal microbiota in the occurrence and development of inflammatory bowel disease
-
11/13/2025 6:51:10 AM | Browse: 156 | Download: 355
|
| 39 |
-
Expanding the role of radiomics and artificial intelligence in the management of inflammatory bowel disease: Insights, opportunities, and challenges
-
11/13/2025 6:51:08 AM | Browse: 182 | Download: 433
|
| 40 |
-
Diagnostic value of artificial intelligence computer assisted diagnosis (computer assisted diagnosis eye function) for colorectal polyps
-
11/7/2025 2:23:21 AM | Browse: 157 | Download: 499
|
| 41 |
-
HLA-C*03:04:01 and HLA-B*15:18:01 but not HLA-DQA1*05 associated with anti- tumor necrosis factor antibody formation in Taiwanese inflammatory bowel disease patients
-
11/6/2025 8:56:35 AM | Browse: 173 | Download: 667
|
| 42 |
-
Growth differentiation factor 15 alters intestinal barrier and increases permeability: A new molecular target in inflammatory bowel disease
-
11/6/2025 8:56:34 AM | Browse: 302 | Download: 561
|
| 43 |
-
Vaccine coverage, antibodies against measles, mumps, rubella, hepatitis B in inflammatory bowel disease and juvenile idiopathic arthritis children
-
10/31/2025 3:03:02 PM | Browse: 163 | Download: 544
|
| 44 |
-
Imaging monitoring contributes to the “treat-to-target” strategy in the management of Crohn’s disease
-
10/27/2025 8:08:14 AM | Browse: 335 | Download: 522
|
| 45 |
-
Role of gut microbiota in the development of metabolic dysfunction-associated steatotic liver disease in inflammatory bowel disease
-
10/27/2025 8:08:13 AM | Browse: 316 | Download: 540
|
| 46 |
-
Artificial intelligence in inflammatory bowel disease: Current applications and future directions
-
10/21/2025 9:08:30 AM | Browse: 313 | Download: 475
|
| 47 |
-
Role of physical exercise, vagal nerve stimulation, and vagotomy in inflammatory bowel disease
-
10/14/2025 7:41:44 AM | Browse: 153 | Download: 366
|
| 48 |
-
Oral microbiome and inflammatory bowel disease: New understanding and call to action
-
10/14/2025 7:41:42 AM | Browse: 286 | Download: 498
|
| 49 |
-
From gut to liver: Exploring the relationship between inflammatory bowel disease and metabolic dysfunction-associated steatotic liver disease
-
9/25/2025 11:24:04 AM | Browse: 290 | Download: 410
|
| 50 |
-
Quercetin pre-treated umbilical cord mesenchymal stem cells alleviate inflammatory bowel disease via IL-10/JAK2/STAT3 signaling
-
9/24/2025 3:48:37 AM | Browse: 186 | Download: 616
|
